Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E van Ede

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|September 24, 1994
[Chronic recurrent polychondritis]A E van Ede, H M Brink, C C Tilanus, et al.
Infection|March 1, 1994
Pneumopericardium complicating invasive pulmonary aspergillosis: case report and reviewA E van Ede, J F Meis, R A Koot, et al.
Seminars in Arthritis and Rheumatism|May 8, 1998
Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicityA E van Ede, R F Laan, H J Blom, et al.
Annals of the Rheumatic Diseases|November 14, 2002
Purine enzymes in patients with rheumatoid arthritis treated with methotrexateA E van Ede, R F J M Laan, R A De Abreu, et al.
Journal of Medical Education and Curricular Development|May 9, 2022
Personal-professional Development Program Fosters Resilience During COVID-PandemicM H J van de Pol, P J M van Gurp, A E van Ede, et al.
Arthritis and Rheumatism|November 17, 2001
The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patientsA E van Ede, R F Laan, H J Blom, et al.
Annals of the Rheumatic Diseases|April 16, 2003
Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritisM Hoekstra, A E van Ede, C J Haagsma, et al.
Rheumatology (Oxford, England)|April 19, 2002
Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritisP Barrera, A van der Maas, A E van Ede, et al.
Rheumatology (Oxford, England)|June 6, 2002
Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritisA E van Ede, R F J M Laan, H J Blom, et al.
Arthritis and Rheumatism|July 24, 2001
Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled studyA E van Ede, R F Laan, M J Rood, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|September 24, 1994
[Chronic recurrent polychondritis]A E van Ede, H M Brink, C C Tilanus, et al.
Infection|March 1, 1994
Pneumopericardium complicating invasive pulmonary aspergillosis: case report and reviewA E van Ede, J F Meis, R A Koot, et al.
Seminars in Arthritis and Rheumatism|May 8, 1998
Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicityA E van Ede, R F Laan, H J Blom, et al.
Annals of the Rheumatic Diseases|November 14, 2002
Purine enzymes in patients with rheumatoid arthritis treated with methotrexateA E van Ede, R F J M Laan, R A De Abreu, et al.
Journal of Medical Education and Curricular Development|May 9, 2022
Personal-professional Development Program Fosters Resilience During COVID-PandemicM H J van de Pol, P J M van Gurp, A E van Ede, et al.
Arthritis and Rheumatism|November 17, 2001
The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patientsA E van Ede, R F Laan, H J Blom, et al.
Annals of the Rheumatic Diseases|April 16, 2003
Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritisM Hoekstra, A E van Ede, C J Haagsma, et al.
Rheumatology (Oxford, England)|April 19, 2002
Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritisP Barrera, A van der Maas, A E van Ede, et al.
Rheumatology (Oxford, England)|June 6, 2002
Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritisA E van Ede, R F J M Laan, H J Blom, et al.
Arthritis and Rheumatism|July 24, 2001
Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled studyA E van Ede, R F Laan, M J Rood, et al.
Pageof 1